Enzymatic kinetic studies with the non-nucleoside HIV reverse transcriptase inhibitor U-9843.
The polymer of ethylenesulfonic acid (U-9843) is a potent inhibitor of HIV-1 RT (reverse transcriptase) and the drug possesses excellent antiviral activity at nontoxic doses in HIV-infected lymphocytes grown in tissue culture. The drug also inhibits RTs isolated from other species such as AMV and MLV retroviruses. Enzymatic kinetic studies of the HIV-1 RT catalyzed RNA-directed DNA polymerase function, using synthetic template:primers, indicate that the drug acts generally noncompetitively with respect to the template:primer binding site but the specific inhibition patterns change somewhat depending on the drug concentration. The inhibitor acts noncompetitively with respect to the dNTP binding sites. Hence, the drug inhibits this RT polymerase function by interacting with a site distinct from the template:primer and dNTP binding sites. In addition, the inhibitor also impairs the DNA-dependent DNA polymerase activity of HIV-1 RT and the RNase H function. This indicates that the drug interacts with a target site essential for all three HIV RT functions addressed (RNA- and DNA-directed DNA polymerases, RNase H).
D000998:Antiviral Agents; D004259:DNA-Directed DNA Polymerase / Q000187:drug effects; D054303:HIV Reverse Transcriptase; D015497:HIV-1; D007700:Kinetics; D011145:Polyvinyls / Q000494:pharmacology*; D018894:Reverse Transcriptase Inhibitors; D013451:Sulfonic Acids
D000998:Antiviral Agents; D011145:Polyvinyls; D018894:Reverse Transcriptase Inhibitors; D013451:Sulfonic Acids; C008959:lyapolate; D054303:HIV Reverse Transcriptase; D004259:DNA-Directed DNA Polymerase